APA (7th ed.) Citation

W, S., JZ, W., X, Z., K, W., S, C., RM, C., . . . F, Z. (2023). Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells. Journal of Cancer, 14(18), 3477. https://doi.org/10.7150/jca.88446

Chicago Style (17th ed.) Citation

W, Shu, et al. "Lapatinib Dysregulates HER2 Signaling and Impairs the Viability of Human Uveal Melanoma Cells." Journal of Cancer 14, no. 18 (2023): 3477. https://doi.org/10.7150/jca.88446.

MLA (9th ed.) Citation

W, Shu, et al. "Lapatinib Dysregulates HER2 Signaling and Impairs the Viability of Human Uveal Melanoma Cells." Journal of Cancer, vol. 14, no. 18, 2023, p. 3477, https://doi.org/10.7150/jca.88446.